09May 2023
Treatment, not delivery, of the late preterm and term fetus with supraventricular arrhythmia

Treatment, not delivery, of the late preterm and term fetus with supraventricular arrhythmia

The article discusses the outcomes of fetuses with sustained supraventricular arrhythmias (SVA) who received in-utero treatment at 35-41 weeks of gestation. The retrospective case series involved 37 fetuses and found that in-utero treatment was successful in restoring sinus rhythm in 95% of cases within a few days. Anti-arrhythmic medications used included flecainide, digoxin, sotalol, and dual therapy. All fetuses were liveborn at 36-41 weeks via vaginal or Cesarean delivery. Recurrence of SVA after birth was observed in 57% of cases. The study suggests that in-utero treatment of near term and term SVA fetuses is highly successful and can help avoid unnecessary Cesarean sections.

  • #gynaecology - ivf

Like

Save

Share